Peptide and protein design for biopharmaceutical applications / ed. Knud J. Jensen
Medienart: |
Buch |
---|
Erscheinungsjahr: |
2009 |
---|---|
Erschienen: |
Chichester: Wiley ; 2009 |
Ausgabe: |
1. publ. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Jensen, Knud J. [HerausgeberIn] |
---|
Links: |
---|
ISBN: |
---|
Nlm: |
2009 L-207 QU 68 |
---|---|
BKL: | |
Themen: |
Aufsatzsammlung |
RVK: |
---|
Anmerkungen: |
Includes index |
---|
Umfang: |
XII, 294 S. ; Ill., graph. Darst. |
---|
Weitere IDs: |
9780470319611 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
1623328535 |
---|
LEADER | 01000cam a2200265 4500 | ||
---|---|---|---|
001 | 1623328535 | ||
003 | DE-627 | ||
005 | 20230905115037.0 | ||
007 | tu | ||
008 | 091105s2009 xxk||||| 00| ||eng c | ||
010 | |a 2009019177 | ||
020 | |a 9780470319611 |9 978-0-470-31961-1 | ||
024 | 3 | |a 9780470319611 | |
035 | |a (DE-627)1623328535 | ||
035 | |a (DE-576)312711972 | ||
035 | |a (DE-599)BSZ312711972 | ||
035 | |a (OCoLC)608678342 | ||
035 | |a (OCoLC)608678342 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
044 | |c XA-GB | ||
050 | 0 | |a RS431.P38 | |
060 | 0 | |a 2009 L-207 | |
060 | 0 | |a QU 68 | |
082 | 0 | |a 615.19 | |
082 | 0 | |a 615/.19 |q LOC |2 22 | |
084 | |a 15,3 |2 ssgn | ||
084 | |a WD 5250 |2 rvk |0 (DE-625)rvk/148196: | ||
084 | |a VC 6250 |q OBV |2 rvk |0 (DE-625)rvk/147086:253 | ||
084 | |a 44.38 |2 bkl | ||
084 | |a 35.76 |2 bkl | ||
084 | |a 44.42 |2 bkl | ||
245 | 1 | 0 | |a Peptide and protein design for biopharmaceutical applications |c ed. Knud J. Jensen |
250 | |a 1. publ. | ||
264 | 1 | |a Chichester |b Wiley |c 2009 | |
300 | |a XII, 294 S. |b Ill., graph. Darst. | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Includes index | ||
505 | 8 | 0 | |t Computational approaches in peptide and protein design : an overview |r Garland Marshall and Gregory Nikiforovich |
505 | 8 | 0 | |t Aspects of peptidomimetics |r Veronique Maes and Dirk Tourwe |
505 | 8 | 0 | |t Design of cyclic peptides |r Oliver Demmer, A. O. Frank, and Horst Kessler |
505 | 8 | 0 | |t Carbohydrates in design of peptides and proteins |r Knud J. Jensen and Jesper Brask |
505 | 8 | 0 | |t De novo design of proteins |r Knud J. Jensen |
505 | 8 | 0 | |t Design of insulin variants for improved treatment of diabetes |r Thomas Høeg-Jensen. |
583 | 1 | |a Archivierung prüfen |c 20200919 |f DE-640 |z 2 |2 pdager | |
650 | 0 | |a Peptide drugs |x Design | |
650 | 0 | |a Protein drugs |x Design | |
650 | 0 | |a Peptides |x Design | |
650 | 0 | |a Protein engineering | |
650 | 0 | |a Peptides |x chemistry | |
650 | 0 | |a Proteins |x chemistry | |
650 | 0 | |a Drug Design | |
650 | 0 | |a Peptide drugs |x Design | |
650 | 0 | |a Protein drugs |x Design | |
650 | 0 | |a Peptides |x Design | |
650 | 0 | |a Protein engineering | |
650 | 2 | |a Peptides |x chemistry | |
650 | 2 | |a Proteins |x chemistry | |
650 | 2 | |a Drug Design | |
655 | 7 | |a Aufsatzsammlung |0 (DE-588)4143413-4 |0 (DE-627)105605727 |0 (DE-576)209726091 |2 gnd-content | |
689 | 0 | 0 | |D s |0 (DE-588)4045125-2 |0 (DE-627)106202766 |0 (DE-576)209064005 |a Peptide |2 gnd |
689 | 0 | 1 | |D s |0 (DE-588)4076388-2 |0 (DE-627)106083007 |0 (DE-576)209201738 |a Proteine |2 gnd |
689 | 0 | 2 | |D s |0 (DE-588)4265444-0 |0 (DE-627)104533722 |0 (DE-576)210631740 |a Molekulardesign |2 gnd |
689 | 0 | 3 | |D s |0 (DE-588)7689632-8 |0 (DE-627)618407677 |0 (DE-576)318506688 |a Biologika |2 gnd |
689 | 0 | |5 (DE-627) | |
689 | 1 | 0 | |D s |0 (DE-588)4045125-2 |0 (DE-627)106202766 |0 (DE-576)209064005 |a Peptide |2 gnd |
689 | 1 | 1 | |D s |0 (DE-588)4346801-9 |0 (DE-627)156887096 |0 (DE-576)211478660 |a Proteindesign |2 gnd |
689 | 1 | 2 | |D s |0 (DE-588)7689632-8 |0 (DE-627)618407677 |0 (DE-576)318506688 |a Biologika |2 gnd |
689 | 1 | |5 (DE-627) | |
700 | 1 | |a Jensen, Knud J. |e hrsg |4 edt | |
856 | 4 | 2 | |u https://swbplus.bsz-bw.de/bsz312711972cov.jpg |m V:DE-576 |m X:wiley |q image/jpeg |v 20091105195118 |3 Cover |
856 | 4 | 2 | |u http://www.loc.gov/catdir/enhancements/fy0913/2009019177-d.html |x Verlag |3 Inhaltstext |
856 | 4 | 2 | |u http://www.loc.gov/catdir/enhancements/fy0913/2009019177-t.html |x Verlag |3 Inhaltsverzeichnis |
889 | |w (DE-627)600127451 | ||
912 | |a GBV_ILN_20 | ||
912 | |a ISIL_DE-84 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OPC-PHA | ||
912 | |a SSG-OPC-DE-84 | ||
912 | |a GBV_ILN_31 | ||
912 | |a ISIL_DE-27 | ||
912 | |a GBV_ILN_69 | ||
912 | |a ISIL_DE-9 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a ISIL_DE-14 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a ISIL_DE-15-292 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a ISIL_DE-16 | ||
912 | |a GBV_ILN_2015 | ||
912 | |a ISIL_DE-93 | ||
935 | |i mdedup | ||
936 | r | v | |a WD 5250 |b Peptide |k Biologie |k Biophysik, Biochemie, Physiologische Chemie |k Spezielle Biochemie und Biophysik |k Biochemie und Biophysik organischer Verbindungen |k Biologisch inaktive Proteine und Proteide insgesamt, auch: Proteinfaltung, Proteinbiosynthese |k Peptide |0 (DE-627)1271573636 |0 (DE-625)rvk/148196: |0 (DE-576)201573636 |
936 | r | v | |a VC 6250 |b Allgemeines |k Chemie und Pharmazie |k Allgemeine Chemie; Mathematik, Statistik und Datenverarbeitung in Chemie und Pharmazie |k Mathematik, Statistik und Datenverarbeitung in Chemie und Pharmazie |k Molecular Modelling Moleküldesign (Molecular design) Arzneimitteldesign (Drug Design) |k Allgemeines |0 (DE-627)1271492113 |0 (DE-625)rvk/147086:253 |0 (DE-576)201492113 |
936 | b | k | |a 44.38 |j Pharmakologie |0 (DE-627)106409743 |
936 | b | k | |a 35.76 |j Aminosäuren |j Peptide |j Eiweiße |x Biochemie |0 (DE-627)181571129 |
936 | b | k | |a 44.42 |j Pharmazeutische Chemie |0 (DE-627)18157179X |
951 | |a BO | ||
953 | |2 045F |a 615.19 | ||
953 | |2 045F |a 615/.19 | ||
980 | |2 20 |1 01 |x 0084 |b 947453113 |c 00 |f --%%-- |d 2895-4484 |e --%%-- |j --%%-- |y k |z 21-10-09 | ||
980 | |2 31 |1 01 |x 0027 |b 1101062924 |c 00 |f J 36 |d PHA:GJ:5350:Jen::2009 |e d |j --%%-- |y z |z 30-10-09 | ||
980 | |2 69 |1 01 |x 0009 |b 1101700122 |c 00 |f UB 660 |d 660/VC 6250 J54 |e u |j --%%-- |y z |z 16-12-09 | ||
980 | |2 2006 |1 01 |x DE-14 |b 3250330752 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 09-11-09 | ||
980 | |2 2010 |1 01 |x DE-15-292 |b 3250330833 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 24-09-18 | ||
980 | |2 2011 |1 01 |x DE-16 |b 3250330892 |c 00 |f --%%-- |d UBN/WD 5250 J54 |e --%%-- |j --%%-- |y l01 |z 05-11-09 | ||
980 | |2 2015 |1 01 |x DE-93 |b 3250330949 |c 00 |f --%%-- |d 5C 6794 |e --%%-- |j --%%-- |y l01 |z 17-11-10 | ||
983 | |2 31 |1 00 |x DE-27 |8 00 |a PHA:GJ:5350 | ||
983 | |2 69 |1 00 |x DE-9 |8 00 |a VC 6250 | ||
983 | |2 69 |1 00 |x DE-9 |8 01 |a VX 8500 | ||
984 | |2 20 |1 01 |x 0084 |a 84$028954484 | ||
984 | |2 31 |1 01 |x 0027 |a 27$024919195 | ||
984 | |2 69 |1 01 |x 0009 |a 9$08214638 | ||
984 | |2 2011 |1 01 |x DE-16 |a 103112206 | ||
985 | |2 31 |1 01 |x 0027 |a U 168319 | ||
985 | |2 69 |1 01 |x 0009 |a 2009.16641 | ||
998 | |2 31 |1 01 |x 0027 |a PHA 201001 | ||
998 | |2 2015 |1 01 |x DE-93 |0 1012 |f 20d |